International Immune-Mediated Inflammatory Eye Disease Genomic Consortium

A collaborative platform for clinicians and researchers with inflammatory eye disease phenotyping and genomic datasets

Eye and DNA illustration

Latest Consortium Documents

The new overview and joining note explain why inflammatory eye disease genetics needs long-term, harmonised international collaboration.

Consortium overview

Summarises the scientific rationale, the limits of isolated studies, and the need for phenotypically enriched global cohorts.

Open PDF

Joining overview

Sets out the strategic vision, governance approach, and the type of academic partnerships the consortium is building.

Open PDF

The 4 Pillars of Success

Building a global framework for genomic discovery

Scale

Large sample sizes are essential for discovery and replication.

Harmonisation

Consistent phenotyping and data standards enable meaningful meta-analysis.

Diversity

Including diverse ancestries improves generalizability and equity.

Trust & Governance

Transparent governance and data sharing build sustainable collaboration.

Why Mature Consortia Matter

In complex immune-mediated diseases, the biggest gains usually come after years of cohort growth, harmonisation, and repeated meta-analysis.

Multiple sclerosis

Long-running collaboration progressed from early GWAS hits to 200+ loci, functional genomics, and severity genetics.

Glaucoma

Large-scale collaboration took years to reach 600k+ samples, enabling robust locus discovery and translational pathway work.

Why i3eye?

Uveitis is rare, clinically heterogeneous, and underpowered in isolated cohorts, so the consortium must mature before translation is realistic.

Ready to Join?

Become part of a global effort to transform inflammatory eye disease research

Explore Membership